Warning Label Urged for Avandia
8/9/2007 by pbowling under AvandiaA U.S. Food and Drug Administration panel has concluded that diabetes patients taking the drug Avandia to treat their condition have a greater risk of heart attack than those taking other drugs to treat their conditions. While the panel did not advise removing the drug from the market, they did say that Avandia needs a stricter warning on its label.
Warning Label Urged for Avandia
The panel’s recommendation likely will only cause more problems for GlaxoSmithKline, the manufacturer of Avandia. Increasing information suggests that GlaxoSmithKline was aware of the dangers of Avandia more than a year before a report linked Avandia to increased heart and kidney risks. More than 20 million Americans and about 170 million people around the world have diabetes.
Related Links:
Avandia Can Stay
Avandia Should Stay on Shelves, U.S. Panel Says
Class-Action Suits Filed Against Avandia Makers
Avandia Critic Nissen Speaks
Tags: Avandia, Drug Recall
This entry was posted on Thursday, August 9th, 2007 at 10:16 pm and is filed under Avandia. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
